Senores Pharma News: Strategic Acquisition of Apnar Pharma
Tuesday, 16 December 2025, 01:23
Senores Pharma Acquisition Overview
Senores Pharma news highlights an important development as the company plans to buy Apnar Pharma.
- Enterprise value: Rs 91 crore
- Pursuit: 100% share capital acquisition in two tranches
- Implications: Strengthening market position and portfolio.
Impact on Pharmaceutical Sector
This acquisition marks a pivotal moment in the pharmaceutical landscape, offering new opportunities and potential growth avenues for Senores Pharma.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.